Medium1/2 relationships sourcedProfile verified Aug 16, 2026

30-Second Executive Brief

Executive Assessment

Aidoc functions as a regional institution within Healthcare & Life Sciences, backed by 55% sourcing coverage, with a stable competitive position.

  • Maintains 2 mapped relationships across the graph
  • 55% sourcing coverage across sourced relationships
  • Tracked as regional institution within the Healthcare & Life Sciences category

Executive Snapshot

Strategic Role
Regional Institution
Sourcing Coverage
55%
View Methodology →

Computed live from this entity's own relationships and evidence: how many relationships carry at least one linked citation, weighted with citation recency and source type — independent of Strategic Importance, and not a prediction. Not a hand-typed number; recalculated on every read.

Ecosystem Influence
Moderate
Strategic Momentum
Insufficient Data

Coverage

Mapped Relationships
2
Technology Domains
4

Strategic Implications

  • Central node connecting multiple strategic ecosystems
  • Directly influences technology and capital flows
  • Material relevance to downstream dependency mapping

Top Opportunities

Continued FDA clearance expansion for its CARE foundation model ahead of a potential IPO.

Top Risks

Regulatory dependence on ongoing FDA clearances for each new clinical AI indication.
Continue to Dependency Graph ↓

Aidoc is a clinical AI company focused on medical imaging analysis and radiology workflow optimization, whose CARE foundation model holds more than 30 FDA clearances — the most in its field, including 11 granted at once in January 2026. Aidoc raised a $150 million Series E in April 2026 led by Goldman Sachs Alternatives, with participation from General Catalyst, SoftBank Vision Fund 2 and NVIDIA's venture arm NVentures, bringing total funding to over $500 million.

Sources

Every claim traced to a primary source — evidence, recent activity, and insider filing behavior, all in one place.

Evidence

1 source

  • SiliconANGLEAidoc raises $150M Series E led by Goldman Sachsnews

Acquisition & Investment Fit

AI-reasoned, generated only from entities already in InsightNodes's own graph — a hypothetical strategic-fit exercise, not real M&A intelligence or a signal that any deal is planned or in progress.

Relationship Map

The relationships surrounding Aidoc — ownership, dependencies, regulation, technology and market context. Click any node to make it the new center, 2 levels deep.

Connection type

Sign in free to click a node and explore →

Click any node to make it the new center. Scroll to zoom, drag to pan.